In the patient presenting for the first time with patches of skindepigmentation, a thorough history and physical examination should be performed, including examination under the Wood's lamp in order to rule out other potentially life-threatening disorders. The initial onset of the condition may be abrupt, however, afterwards it usually progresses slowly, with expansion of skindepigmentation with no concomitant symptoms.[3][4][5][6] It is important to inquire about history of occupational exposures, since those may aggravate underlying vitiligolesions or may lead to depigmentation areas, with no connection to the disease.[7] There may be two major subdivisions of vitiligo which may influence the presence of different characteristics and the natural history of the disease. They may be present individually or concomitantly, in which case the segmental lesions will respond poorly to the treatment.[3][8]
Considering that halo nevi are more common in vitiligo patients than in the population in general, it is important to discuss personal or family history of such. This is an important step since existence of multiple halo nevi, is a common indicator of autoimmunity against the nevi, which increases the risk of vitiligo in the presence of history of disease in the family. It is also important to note the skin type of the patient.[10][11]
Since vitiligo is often associated with other autoimmune diseases, it is important to evaluate the presence of such during the consult:
↑Soutor, Carol (2013). Clinical dermatology. New York: McGraw-Hill Education/Lange Medical Books. ISBN978-0-07-177296-9.
↑Taïeb, Alain; Picardo, Mauro (2007). "The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force". Pigment Cell Research. 20 (1): 27–35. doi:10.1111/j.1600-0749.2006.00355.x. ISSN0893-5785.
↑Rook, Arthur (2004). Rook's textbook of dermatology. Malden, Mass: Blackwell Science. ISBN0-632-06429-3.
↑Cunliffe, W. J.; Hall, R.; Newell, D. J.; Stevenson, C. J. (1968). "VITILIGO, THYROID DISEASE AND AUTOIMMUNITY". British Journal of Dermatology. 80 (3): 135–139. doi:10.1111/j.1365-2133.1968.tb12282.x. ISSN0007-0963.
↑Frenk, E. (1969). "Dépigmentations vitiligineuses chez des patients atteints de mélanomes malins". Dermatology. 139 (1): 84–91. doi:10.1159/000253894. ISSN1421-9832.